Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-13

Clinical Trial Update: A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study assessing single-dose tadalafil gummy formulations in healthy volunteers. The trial is sponsored by Seattle Gummy Company and is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

Sponsor: Seattle Gummy Company | Conditions: Erectile Dysfunction | Phase 1 | Status: NOT_YET_RECRUITING